The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The impact of diabetes‐related complications on healthcare costs: new results from the UKPDS (UKPDS 84)
Open accessAbstract
Aims: To estimate the immediate and long‐term inpatient and non‐inpatient costs for Type 2 diabetes‐related complications. Methods: The costs of all consultations, visits, admissions and procedures associated with diabetes‐related complications during UK Prospective Diabetes Study post‐trial monitoring in the period 1997–2007 were estimated using hospitalization records for 2791 patients in England and resource use questionnaires that were administered to 3589 patients across the UK. Results: The estimated (95% CI) inpatient care costs (in 2012 pounds sterling) in the event year for the example of a 60‐year‐old man were: non‐fatal ischaemic heart disease £9767 (£7038–£12 696); amputation £9546 (£6416–£13 463); non‐fatal stroke £6805 (£3856–£10 278); non‐fatal myocardial infarction £6379 (£4290–£8339); fatal stroke £3954 (£2012–£6428); fatal ischaemic heart disease £3766 (£746–£5512); heart failure £3191 (£1678–4903); fatal myocardial infarction £1521 (£647–£2670); and blindness in one eye £1355 (£415–£2655). In subsequent years, estimated (95% CI) costs ranged from £1792 (£1060–£2943) for amputations to £453 (£315–£691) for blindness in one eye. Costs of non‐inpatient healthcare in the event year were: amputation £2699 (£1409–£4126); blindness in one eye £1790 (£878–£3056); non‐fatal stroke £1019 (£770–£1499); nonfatal myocardial infarction £1963 (£794–£1157); heart failure £979 (£708–£1344); non‐fatal ischaemic heart disease £864 (£718–£1014); and cataract extraction £700 (£619–£780). In each subsequent year, non‐inpatient costs ranged from £1611 (£1193–£2116) for amputations to £654 (£572–£799) for ischaemic heart disease. Conclusions: Diabetic complications are associated with substantial immediate and long‐term healthcare costs. Our comprehensive new estimates of these costs, derived from detailed recent UK Prospective Diabetes Study post‐trial data, should aid researchers and health policy analyses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clarke, P. M., Glasziou, P., Patel, A., Chalmers, J., Woodward, M., Harrap, S. B., Salomon, J. A., & on behalf of the ADVANCE Collaborative Group (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000236 · Cited by 159
Cited by
Evaluating Digital Health Interventions
Murray, E., Hekler, E. B., Andersson, G., Collins, L. M., Doherty, A., Hollis, C., Rivera, D. E., West, R., & Wyatt, J. C. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.06.008 · Cited by 847
Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review
Einarson, T. R., Acs, A., Ludwig, C., & Panton, U. H. (2018) · Value in Health · doi:10.1016/j.jval.2017.12.019 · Cited by 305
Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany
Kähm, K., Laxy, M., Schneider, U., Rogowski, W. H., Lhachimi, S. K., & Holle, R. (2018) · Diabetes Care · doi:10.2337/dc17-1763 · Cited by 141
The economics of vision impairment and its leading causes: A systematic review
Marques, A. P., Ramke, J., Cairns, J., Butt, T., Zhang, J. H., Jones, I., Jovic, M., Nandakumar, A., Faal, H., Taylor, H., et al. (2022) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101354 · Cited by 137
Viljoen, A., Hoxer, C. S., Johansen, P., Malkin, S., Hunt, B., & Bain, S. C. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13564 · Cited by 45
Metadata
- Authors
- Alva, M. L., Gray, A., Mihaylova, B., Leal, J., & Holman, R. R.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2015-01-07
- Volume
- 32
- Issue
- 4
- Pages
- 459-466
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2041508558
- Cited by
- 192
- References
- 3
- FWCI
- 36.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.